These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28285082)

  • 21. Are maintenance and continuous therapies indicated for every patient with multiple myeloma?
    Musto P; Montefusco V
    Expert Rev Hematol; 2016 Aug; 9(8):743-51. PubMed ID: 27268855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of complete response in outcomes in myeloma.
    Nooka A; Kaufman J; Lonial S
    Cancer J; 2009; 15(6):465-72. PubMed ID: 20010165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the significance of molecular remission in multiple myeloma?
    Tricot GJ
    Clin Adv Hematol Oncol; 2007 Feb; 5(2):91-5. PubMed ID: 17344796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous treatment in multiple myeloma: the future?
    Vande Broek I; Jacobs P
    Transfus Apher Sci; 2013 Oct; 49(2):147-50. PubMed ID: 24074557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in understanding multiple myeloma.
    Hari P
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):267-271. PubMed ID: 28633036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practical approach to relapsed multiple myeloma.
    Mikhael JR
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):262-7. PubMed ID: 25696865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Review on High-Risk Multiple Myeloma.
    Chan HSH; Chen CI; Reece DE
    Curr Hematol Malig Rep; 2017 Apr; 12(2):96-108. PubMed ID: 28317082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The road to treating smoldering multiple myeloma.
    Korde N; Mailankody S; Landgren O
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S59-64. PubMed ID: 25486957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation.
    Blimark C; Veskovski L; Westin J; Rödjer S; Brune M; Hjorth M; Holmberg E; Andersson PO; Mellqvist UH
    Eur J Haematol; 2011 Aug; 87(2):117-22. PubMed ID: 21535157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current therapeutic strategies for multiple myeloma.
    Torimoto Y; Shindo M; Ikuta K; Kohgo Y
    Int J Clin Oncol; 2015 Jun; 20(3):423-30. PubMed ID: 25855312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low-dose thalidomide in refractory and relapsing multiple myeloma].
    Radocha J; Maisnar V
    Vnitr Lek; 2007 Feb; 53(2):129-34. PubMed ID: 17419173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to use new biology to guide therapy in multiple myeloma.
    Morgan GJ; Kaiser MF
    Hematology Am Soc Hematol Educ Program; 2012; 2012():342-9. PubMed ID: 23233602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.
    Ozaki S; Harada T; Saitoh T; Shimazaki C; Itagaki M; Asaoku H; Kuroda Y; Chou T; Yoshiki Y; Suzuki K; Murakami H; Hayashi K; Mina R; Palumbo A; Shimizu K; ;
    Acta Haematol; 2014; 132(2):211-9. PubMed ID: 24662986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards Stratified Medicine in Plasma Cell Myeloma.
    Egan P; Drain S; Conway C; Bjourson AJ; Alexander HD
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival.
    Jimenez-Zepeda VH; Mikhael J; Winter A; Franke N; Masih-Khan E; Trudel S; Chen C; Kukreti V; Reece DE
    Biol Blood Marrow Transplant; 2012 May; 18(5):773-9. PubMed ID: 22062804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of autologous transplantation in multiple myeloma: significant survival benefit of novel drugs in post-transplantation relapse.
    Krejci M; Scudla V; Tothova E; Schutzova M; Koza V; Adam Z; Krivanova A; Pour L; Buchler T; Sandecka V; Kralova D; Zahradova L; Vorlicek J; Mayer J; Hajek R
    Clin Lymphoma Myeloma; 2009 Dec; 9(6):436-42. PubMed ID: 19951883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International uniform response criteria for multiple myeloma.
    Durie BG; Harousseau JL; Miguel JS; Bladé J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Cavo M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV;
    Leukemia; 2006 Sep; 20(9):1467-73. PubMed ID: 16855634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.
    Dhakal B; D'Souza A; Martens M; Kapke J; Harrington AM; Pasquini M; Saber W; Drobyski WR; Zhang MJ; Hamadani M; Hari PN
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):379-86. PubMed ID: 27160644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
    Podar K; Jager D
    Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.